Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in the Treatment of Coronary Artery Disease in Patients With Diabetes Mellitus
- 15 July 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (2) , 187-192
- https://doi.org/10.1016/j.amjcard.2006.01.074
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Impact of Treatment of Coronary Artery Disease With Sirolimus-Eluting Stents on Outcomes of Diabetic and Nondiabetic PatientsThe American Journal of Cardiology, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: The TAXUS-IV trialJournal of the American College of Cardiology, 2005
- The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registryJournal of the American College of Cardiology, 2005
- Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of ClopidogrelCirculation, 2004
- Impact of Sirolimus-Eluting Stents on Outcome in Diabetic PatientsCirculation, 2004
- Short- and long-term results after multivessel stenting in diabetic patientsJournal of the American College of Cardiology, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients Insights from the RAVEL TrialEuropean Heart Journal, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003